Daily Stock Opinions and Ratings

Opinions

Jim Cramer - Mad MoneyCanopy GrowthCGCCOMMENTFeb 05, 2021

Lots of excitement here with the Democrats in the White House and wanting to decriminalizing cannabis, but Canopy needs full decriminalizing if it will keep going higher. Eventually, we'll get there, but likely not fast enough for the bulls. It reports Tuesday.

Jim Cramer - Mad Money

Unknown

Unlock Rating

$42.93

Stock price when the opinion was issued

$0.97

As of Jun 18, 2026. Market Open.

Healthcare

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

COMMENT

Will Constellation drop Canopy? No. The CEO believes that one day cannabis will be legalized nationally. He agrees, but doesn't know when this will happen.

DON'T BUY

Until Washington legalizes weed, you can't own this stock.

DON'T BUY

Isn't recommending any cannabis stock, which need federal government approval of weed to rise.

DON'T BUY

At $9, you could buy it, but this had a weak quarter. Run by a good CEO and Constellation Brands has a stake in it. Problem is, he doesn't like the cannabis business--it's overhyped like gambling now.

DON'T BUY

The core business isn't that good. It's too late to sell, but don't buy any shares now.

DON'T BUY

He prefers Constellation Brand, an integrated weed company.

DON'T BUY

We need federal legalization now; he can't embrace the weed group until that legislation. He'd rather hedge in this space by buying Constellation Brands.

BUY

The cannabis sector under Biden and the Democrats He likes the long-term in cannabis. Canopy has the capital and strong management to stay in the long game. Also, he likes Aphria.

BUY

Canopy is the way to play cannabis as we enter a Biden adminIstration. Also, Canopy has the interest of Constellation Brands.

Premium content

It's a Monthly Gems opinion which is available only for Stockchase Premium

Curated by Allan Tong since 2019.
99+ opinions with 4.15 rating.

TOP PICK

Biden's running mate, Kamala Harris came out during her vice-presidential debate to decriminalize cannabis. On Tuesday, voters in four American states to legalize weed, plus two more to allow medical marijuana. That means 16 states have decriminalized cannabis, plus 15 have legalized it. On Wednesday, Canadian weed stocks soared and continued to climb on Thursday. Is the weed (euphoria) already baked in? Will this rally crash into a bummer? The king of Canadian cannabis, Canopy, has seen wild swings this week on the Nasdaq, so there is risk, but also enormous reward. On Thursday, CGC-N popped over 11%. Canadian cannabis should continue to rise until American lawmakers allow their country's own growers to publicly trade. When that happens, who knows?

WEAK BUY

Investors are betting on the Blue Wave, a Democratic sweep. Though Biden hasn't said he'll legalize cannabis, the Dems will make it easier for the cannabis industry to operate. Of note, recreational grass is already legal in 11 states and DC; recreational weed is on the ballot in three states on Nov. 3; and two-thirds of American believe it should be legal, even more when it comes to medicinal grass. No, we won't see a boom in Canadian weed, but instead American companies because American politicians need to serve American businesses first. Canada teaches us that when you legalize weed, EVERYBODY grows it, supply surges, driving the price down and companies don't make money. The one exception is Canopy. One reason is its relationship with Constellation Brands and carries the potential of weed-infused drinks and a leg up against competitors. Canopy itself has been a dog, but is lately showing some life.

Most Recent Experts

Stockchase Insights

5i Research

Brian Acker, CA

Acker Finley Inc.

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

David Burrows

Barometer Capital Management